Showing results (151-160 of 181) with videos related to

Sort By:
Pageof 19
Journal of Pain and Symptom Management|July 27, 2017
Oxaliplatin-Induced Peripheral Neuropathy and Identification of Unique Severity Groups in Colorectal CancerKathleen A Griffith, Shijun Zhu, Meg Johantgen, et al.
Nature Communications|October 12, 2016
Challenges and disparities in the application of personalized genomic medicine to populations with African ancestryMichael D Kessler, Laura Yerges-Armstrong, Margaret A Taub, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 10, 2004
A Phase I trial of TNFerade biologic in patients with soft tissue sarcoma in the extremitiesArno J Mundt, Srinivasan Vijayakumar, John Nemunaitis, et al.
Clinical Pharmacology and Therapeutics|January 29, 2011
Immunogenicity and smoking-cessation outcomes for a novel nicotine immunotherapeuticD K Hatsukami, D E Jorenby, D Gonzales, et al.
Human Gene Therapy|January 10, 2002
Analysis of risk factors for local delivery of low- and intermediate-dose adenovirus gene transfer vectors to individuals with a spectrum of comorbid conditionsRonald G Crystal, Ben-Gary Harvey, Juan P Wisnivesky, et al.
Biotechnology Reports (Amsterdam, Netherlands)|January 11, 2021
Effects of biocholine powder supplementation in ewe lambs: Growth, rumen fermentation, antioxidant status, and metabolismKaroline W Leal, Davi F Alba, Marily G Cunha, et al.
Proceedings of the National Academy of Sciences of the United States of America|June 28, 2018
Evolutionary genomic dynamics of Peruvians before, during, and after the Inca EmpireDaniel N Harris, Wei Song, Amol C Shetty, et al.
Cancer Research Communications|October 29, 2024
SpliceMutr Enables Pan-Cancer Analysis of Splicing-Derived Neoantigen Burden in TumorsTheron Palmer, Michael D Kessler, Xiaoshan M Shao, et al.
Psychological Medicine|May 6, 2021
Predicting prognosis for adults with depression using individual symptom data: a comparison of modelling approachesJ E J Buckman, Z D Cohen, C O'Driscoll, et al.
Gene Therapy|June 23, 2006
Angiogenic gene therapy in patients with nonrevascularizable ischemic heart disease: a phase 2 randomized, controlled trial of AdVEGF(121) (AdVEGF121) versus maximum medical treatmentD J Stewart, J D Hilton, J M O Arnold, et al.
Pageof 19